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Dr. Noboru Mizushima
Winner of the 2007 FEBS Letters
Young Scientist AwardDr. Noboru Mizushima, professor at the Tokyo Medical and
Dental University in Japan, won this year’s FEBS Letters
Young Scientist Award for his paper on the role of autophagy
in controlling cell size [1].
Noboru was originally inspired to study human biology by his
father, who is an MD and is also involved in research. After his
doctoral studies in rheumatology, Noboru headed towards
new frontiers by switching to study autophagy, a largely unex-
plored ﬁeld to which he has by now made major contributions.What is autophagy?
Autophagy is a protein degradation system within the cell. The
process involves a pathway through which cytoplasmic constit-
uents are initially enclosed in a vesicle called autophagosome.
The autophagosome eventually fuses to the lysosome, which is
a membrane-bound organelle rich in proteolytic enzymes, and
here the cytoplasm-derived material gets completely degraded.Why did you choose to study autophagy?
There are basically two systems in the cell that lead to protein
degradation: one is the well-known ubiquitin-proteasome
pathway, which has attracted a lot of attention in the past
years within the scientiﬁc community, to the point of winning
the Nobel Prize in Chemistry in 2004; and the other is autoph-
agy, which has only recently started to be understood. What
distinguishes one degradation pathway from the other is selec-
tivity. While ubiquitin targets a protein for degradation
through the proteasome in a highly selective manner, autoph-
agy randomly induces the degradation of whole portions of the
cytoplasm with no exceptions. We have found that despite its
seemingly casual targets for bulk degradation, autophagy is
highly regulated and has precise physiological roles both at
the cellular level and within the organism [1–3]. I ﬁnd this con-
cept fascinating and at the same time highly interesting.What were the major insights of your award-winning FEBS
Letters paper?
One of the biggest challenges when studying autophagy is to in-
hibit the pathway in a very speciﬁc manner, i.e. without altering
other cellular pathways or processes. A commonly used com-
pound is the PI3K inhibitor, which blocks autophagy. How-
ever, PI3K is involved in numerous other pathways, and
therefore this method is not ‘‘clean’’ or speciﬁc enough. On
the other hand, other techniques such as RNA interference or
gene targeting can be more speciﬁc, but they are not reversible
and not always successful. In this study we have developed a
mouse ﬁbroblast cell line in which autophagy can be reversibly
suppressed with the Tet-oﬀ system. Using this cell line we were
able to show that autophagy has a role in controlling cell size.0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
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No, we have autophagy-defective mice in the lab, and their
body size is not larger than average. However, we expect
autophagy to have an important role in inducing cell atrophy
during muscle wasting. Moreover, we have recently shown that
autophagy also has a fundamental role in mice during the early
neonatal starvation period, as a source of amino acids prior to
lactation [2].Why did you choose FEBS Letters to publish this paper?
When we started presenting our autophagy-regulatable cell
line at conferences, we attracted the interest of many research-
ers in the ﬁeld who asked for permission to use the cells for
their own experiments. We therefore needed to publish our
study as rapidly as possible before other laboratories published
their own ﬁndings obtained with our cell-line. We chose FEBS
Letters because it is well known for its fast publication and it is
available worldwide in scientiﬁc libraries.Did you get interesting feedback after this publication?
We did indeed. We had many more requests for our cell-line.
Moreover, the paper attracted the interest of, and was recently
cited by, scientists who study the role of autophagy in control-
ling cell growth in drosophila [4]. Understanding the process in
a mammalian system is a considerable step forward.How did it feel to win the FEBS Letters Young Scientist Award?
I was both surprised and honoured. In Japan it is not easy to
get an independent position before forty years of age. I feel I
was very lucky to have the possibility to be the corresponding
author of this paper in the ﬁrst place, and even more so to win
the prize!Do you have any special wish to fulﬁll with the prize?
I think I will share it with my lab members. I want them to en-
joy science as I do, and to feel the excitement for their ﬁndings.
The FEBS Letters award is a good encouragement in this re-
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